The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells?

Chemical Communications Pub Date: 2014-02-28 DOI: 10.1039/C4CC00419A

Abstract

Asplatin, a fusion of aspirin and cisplatin, exhibits significant cytotoxicity in tumor cells and almost fully overcomes the drug resistance of cisplatin resistant cells. Asplatin is highly accumulated in cancer cells and is activated upon the reduction by ascorbic acid.

Graphical abstract: The ligation of aspirin to cisplatin demonstrates significant synergistic effects on tumor cells
Recommended Literature